"sample_name"	"unique_patient_ID"	"alt_sample_name"	"sample_type"	"primarysite"	"summarygrade"	"G"	"summarystage"	"T"	"N"	"M"	"Dstage"	"age_at_initial_pathologic_diagnosis"	"days_to_tumor_recurrence"	"recurrence_status"	"days_to_death"	"vital_status"	"family_history"	"msi"	"location"	"summarylocation"	"gender"	"kras"	"braf"	"line1"	"tumor_size"	"mutation_apc"	"lymphnodesremoved"	"lymphnodesinvaded"	"stageall"	"ethnicity"	"dfs_status"	"days_to_recurrence_or_death"	"disease_specific_mortality"	"batch"	"drug_name"	"drug_treatment"	"drug_response"	"preop_drug_treatment"	"preop_drug_name"	"fu"	"bevacizumab"	"irinotecan"	"cetuximab"	"capecitabine"	"dexamethasone"	"gcsf"	"fudr"	"folfiri"	"folfox"	"leucovorin"	"mitomycin"	"platin"	"panitumumab"	"pegfilgrastim"	"raltitrexed"	"ancillary"	"chemotherapy"	"moltherapy"	"uncurated_author_metadata"
"TCGA-DY-A1DE-01A-11R-A155-07"	"TCGA-DY-A1DE"	"TCGA-DY-A1DE-01A-11R-A155-07"	"tumor"	"re"	NA	NA	"early"	"3"	"0"	"0"	NA	56	3316	"recurrence"	NA	"living"	NA	"MSS"	"rectum"	"l"	"f"	"mutant"	NA	NA	NA	NA	14	0	"2"	"caucasian"	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"age_at_initial_pathologic_diagnosis: 56///anatomic_neoplasm_subdivision: Rectum///b_symptoms: NA///bcr_patient_uuid: 5555fbdd-962f-4d79-b36c-ae3c3cc4aff4///braf_gene_analysis_performed: YES///braf_gene_analysis_result: Normal///circumferential_resection_margin: NA///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: NA///days_to_birth: -20504///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: 3683///days_to_psa: NA///ethnicity: NOT HISPANIC OR LATINO///extranodal_involvement: NA///gender: FEMALE///gleason_score: NA///height: 160///histological_type: Rectal Adenocarcinoma///history_of_colon_polyps: NO///history_of_neoadjuvant_treatment: No///icd_10: C20///icd_o_3_histology: 8140/3///icd_o_3_site: C20.9///informed_consent_verified: YES///kras_gene_analysis_performed: YES///kras_mutation_codon: 61///kras_mutation_found: YES///loss_expression_of_mismatch_repair_proteins_by_ihc: NA///loss_expression_of_mismatch_repair_proteins_by_ihc_result: NA///lymph_node_examined_count: 14///lymphatic_invasion: NO///microsatellite_instability: NO///non_nodal_tumor_deposits: NA///number_of_abnormal_loci: 0///number_of_first_degree_relatives_with_cancer_diagnosis: 0///number_of_loci_tested: 5///number_of_lymphnodes_positive_by_he: 0///number_of_lymphnodes_positive_by_ihc: NA///pathologic_M: M0///pathologic_N: N0///pathologic_T: T3///pathologic_stage: Stage IIA///patient_id: A1DE///perineural_invasion_present: NA///preoperative_pretreatment_cea_level: NA///primary_lymph_node_presentation_assessment: YES///primary_pattern: NA///prior_dx: No///psa_value: NA///race: WHITE///residual_tumor: NA///secondary_pattern: NA///synchronous_colon_cancer_present: NO///system_version: NA///tertiary_pattern: NA///tissue_source_site: DY///tumor_tissue_site: Rectum///venous_invasion: NO///weight: 70///year_of_initial_pathologic_diagnosis: 2001///additional_pharmaceutical_therapy: NA///additional_radiation_therapy: NA///additional_surgery_locoregional_procedure: NO///additional_surgery_metastatic_procedure: NA///bcr_followup_uuid: EB9A942F-CF37-4E8D-98D9-791973F9D383///date_of_form_completion: 2011-12-5///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: NA///days_to_last_followup: 3932///days_to_new_tumor_event_after_initial_treatment: 3316///followup_case_report_form_submission_reason: Scheduled Follow-up Submission///new_tumor_event_after_initial_treatment: YES///person_neoplasm_cancer_status: NA///radiation_therapy: NA///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: NA///vital_status: Alive///Extract.Name: TCGA-DY-A1DE-01A-11R-A155-07///unique_patient_id: TCGA-DY-A1DE"
"TCGA-DY-A1DF-01A-11R-A155-07"	"TCGA-DY-A1DF"	"TCGA-DY-A1DF-01A-11R-A155-07"	"tumor"	"re"	NA	NA	"late"	"3"	"2"	"0"	NA	73	NA	NA	NA	NA	NA	"MSS"	"rectosigmoid"	"l"	"f"	"mutant"	NA	NA	NA	NA	15	5	"3"	"caucasian"	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"age_at_initial_pathologic_diagnosis: 73///anatomic_neoplasm_subdivision: Rectosigmoid Junction///b_symptoms: NA///bcr_patient_uuid: b1a787b6-8e94-4b1b-b063-3338c80eef78///braf_gene_analysis_performed: YES///braf_gene_analysis_result: Normal///circumferential_resection_margin: NA///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: NA///days_to_birth: -26763///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: 734///days_to_psa: NA///ethnicity: NOT HISPANIC OR LATINO///extranodal_involvement: NA///gender: FEMALE///gleason_score: NA///height: 156///histological_type: Rectal Adenocarcinoma///history_of_colon_polyps: NA///history_of_neoadjuvant_treatment: No///icd_10: C19///icd_o_3_histology: 8140/3///icd_o_3_site: C19.9///informed_consent_verified: YES///kras_gene_analysis_performed: YES///kras_mutation_codon: 13///kras_mutation_found: YES///loss_expression_of_mismatch_repair_proteins_by_ihc: NA///loss_expression_of_mismatch_repair_proteins_by_ihc_result: NA///lymph_node_examined_count: 15///lymphatic_invasion: NA///microsatellite_instability: NO///non_nodal_tumor_deposits: NA///number_of_abnormal_loci: 0///number_of_first_degree_relatives_with_cancer_diagnosis: 0///number_of_loci_tested: 5///number_of_lymphnodes_positive_by_he: 5///number_of_lymphnodes_positive_by_ihc: NA///pathologic_M: M0///pathologic_N: N2///pathologic_T: T3///pathologic_stage: Stage IIIC///patient_id: A1DF///perineural_invasion_present: NA///preoperative_pretreatment_cea_level: NA///primary_lymph_node_presentation_assessment: YES///primary_pattern: NA///prior_dx: No///psa_value: NA///race: WHITE///residual_tumor: NA///secondary_pattern: NA///synchronous_colon_cancer_present: NO///system_version: NA///tertiary_pattern: NA///tissue_source_site: DY///tumor_tissue_site: Rectum///venous_invasion: NA///weight: 75///year_of_initial_pathologic_diagnosis: 2001///additional_pharmaceutical_therapy: NA///additional_radiation_therapy: NA///additional_surgery_locoregional_procedure: NA///additional_surgery_metastatic_procedure: NA///bcr_followup_uuid: NA///date_of_form_completion: NA///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: NA///days_to_last_followup: NA///days_to_new_tumor_event_after_initial_treatment: NA///followup_case_report_form_submission_reason: NA///new_tumor_event_after_initial_treatment: NA///person_neoplasm_cancer_status: NA///radiation_therapy: NA///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: NA///vital_status: NA///Extract.Name: TCGA-DY-A1DF-01A-11R-A155-07///unique_patient_id: TCGA-DY-A1DF"
"TCGA-DY-A0XA-01A-11R-A155-07"	"TCGA-DY-A0XA"	"TCGA-DY-A0XA-01A-11R-A155-07"	"tumor"	"re"	NA	NA	"early"	"3"	"0"	"0"	NA	57	NA	"norecurrence"	NA	"living"	NA	"MSS"	"rectosigmoid"	"l"	"f"	"wt"	NA	NA	NA	NA	14	0	"2"	"caucasian"	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"age_at_initial_pathologic_diagnosis: 57///anatomic_neoplasm_subdivision: Rectosigmoid Junction///b_symptoms: NA///bcr_patient_uuid: 9df9af6b-00b0-47af-aac7-b52dac399ba5///braf_gene_analysis_performed: YES///braf_gene_analysis_result: Normal///circumferential_resection_margin: NA///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: NA///days_to_birth: -21115///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: 3635///days_to_psa: NA///ethnicity: NOT HISPANIC OR LATINO///extranodal_involvement: NA///gender: FEMALE///gleason_score: NA///height: 159///histological_type: Rectal Adenocarcinoma///history_of_colon_polyps: NO///history_of_neoadjuvant_treatment: No///icd_10: C19///icd_o_3_histology: 8140/3///icd_o_3_site: C19.9///informed_consent_verified: YES///kras_gene_analysis_performed: YES///kras_mutation_codon: NA///kras_mutation_found: NO///loss_expression_of_mismatch_repair_proteins_by_ihc: NA///loss_expression_of_mismatch_repair_proteins_by_ihc_result: NA///lymph_node_examined_count: 14///lymphatic_invasion: NO///microsatellite_instability: NO///non_nodal_tumor_deposits: NA///number_of_abnormal_loci: 0///number_of_first_degree_relatives_with_cancer_diagnosis: 0///number_of_loci_tested: 6///number_of_lymphnodes_positive_by_he: 0///number_of_lymphnodes_positive_by_ihc: NA///pathologic_M: M0///pathologic_N: N0///pathologic_T: T3///pathologic_stage: Stage IIA///patient_id: A0XA///perineural_invasion_present: NA///preoperative_pretreatment_cea_level: NA///primary_lymph_node_presentation_assessment: YES///primary_pattern: NA///prior_dx: No///psa_value: NA///race: WHITE///residual_tumor: NA///secondary_pattern: NA///synchronous_colon_cancer_present: NO///system_version: NA///tertiary_pattern: NA///tissue_source_site: DY///tumor_tissue_site: Rectum///venous_invasion: NO///weight: 64///year_of_initial_pathologic_diagnosis: 2001///additional_pharmaceutical_therapy: NA///additional_radiation_therapy: NA///additional_surgery_locoregional_procedure: NA///additional_surgery_metastatic_procedure: NA///bcr_followup_uuid: 3CD987E9-DD78-41B5-950C-F0AA56C3F6D2///date_of_form_completion: 2011-10-25///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: NA///days_to_last_followup: 3845///days_to_new_tumor_event_after_initial_treatment: NA///followup_case_report_form_submission_reason: Scheduled Follow-up Submission///new_tumor_event_after_initial_treatment: NO///person_neoplasm_cancer_status: NA///radiation_therapy: NA///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: NA///vital_status: Alive///Extract.Name: TCGA-DY-A0XA-01A-11R-A155-07///unique_patient_id: TCGA-DY-A0XA"
"TCGA-DY-A1H8-01A-21R-A155-07"	"TCGA-DY-A1H8"	"TCGA-DY-A1H8-01A-21R-A155-07"	"tumor"	"re"	NA	NA	"late"	"2"	"1"	"0"	NA	77	NA	"norecurrence"	991	"deceased"	NA	NA	"rectum"	"l"	"f"	"mutant"	NA	NA	NA	NA	7	1	"3"	"caucasian"	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"age_at_initial_pathologic_diagnosis: 77///anatomic_neoplasm_subdivision: Rectum///b_symptoms: NA///bcr_patient_uuid: c2395f04-e248-4091-855d-802b1b871f29///braf_gene_analysis_performed: NO///braf_gene_analysis_result: NA///circumferential_resection_margin: NA///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: NA///days_to_birth: -28459///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: 991///days_to_psa: NA///ethnicity: NOT HISPANIC OR LATINO///extranodal_involvement: NA///gender: FEMALE///gleason_score: NA///height: 160///histological_type: Rectal Adenocarcinoma///history_of_colon_polyps: NA///history_of_neoadjuvant_treatment: No///icd_10: C20///icd_o_3_histology: 8140/3///icd_o_3_site: C20.9///informed_consent_verified: YES///kras_gene_analysis_performed: YES///kras_mutation_codon: 12///kras_mutation_found: YES///loss_expression_of_mismatch_repair_proteins_by_ihc: NA///loss_expression_of_mismatch_repair_proteins_by_ihc_result: NA///lymph_node_examined_count: 7///lymphatic_invasion: NA///microsatellite_instability: NA///non_nodal_tumor_deposits: NA///number_of_abnormal_loci: 0///number_of_first_degree_relatives_with_cancer_diagnosis: 0///number_of_loci_tested: 0///number_of_lymphnodes_positive_by_he: 1///number_of_lymphnodes_positive_by_ihc: NA///pathologic_M: M0///pathologic_N: N1///pathologic_T: T2///pathologic_stage: Stage IIIA///patient_id: A1H8///perineural_invasion_present: NA///preoperative_pretreatment_cea_level: NA///primary_lymph_node_presentation_assessment: YES///primary_pattern: NA///prior_dx: No///psa_value: NA///race: WHITE///residual_tumor: NA///secondary_pattern: NA///synchronous_colon_cancer_present: NO///system_version: NA///tertiary_pattern: NA///tissue_source_site: DY///tumor_tissue_site: Rectum///venous_invasion: NA///weight: 40///year_of_initial_pathologic_diagnosis: 2000///additional_pharmaceutical_therapy: NA///additional_radiation_therapy: NA///additional_surgery_locoregional_procedure: NA///additional_surgery_metastatic_procedure: NA///bcr_followup_uuid: 3B7C3CF1-2960-4E6F-B34C-DCC36970CBF5///date_of_form_completion: 2011-12-2///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: 991///days_to_last_followup: 991///days_to_new_tumor_event_after_initial_treatment: NA///followup_case_report_form_submission_reason: Scheduled Follow-up Submission///new_tumor_event_after_initial_treatment: NO///person_neoplasm_cancer_status: NA///radiation_therapy: NA///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: NA///vital_status: Dead///Extract.Name: TCGA-DY-A1H8-01A-21R-A155-07///unique_patient_id: TCGA-DY-A1H8"
"TCGA-DY-A1DC-01A-31R-A155-07"	"TCGA-DY-A1DC"	"TCGA-DY-A1DC-01A-31R-A155-07"	"tumor"	"re"	NA	NA	"early"	"3"	"0"	"0"	NA	72	630	"recurrence"	1257	"deceased"	NA	"MSS"	"rectosigmoid"	"l"	"f"	"wt"	NA	NA	NA	NA	16	0	"2"	"caucasian"	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"age_at_initial_pathologic_diagnosis: 72///anatomic_neoplasm_subdivision: Rectosigmoid Junction///b_symptoms: NA///bcr_patient_uuid: 205f30ff-fb10-44a8-a1c6-c538de100db5///braf_gene_analysis_performed: YES///braf_gene_analysis_result: Normal///circumferential_resection_margin: NA///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: NA///days_to_birth: -26436///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: 1257///days_to_psa: NA///ethnicity: NOT HISPANIC OR LATINO///extranodal_involvement: NA///gender: FEMALE///gleason_score: NA///height: NA///histological_type: Rectal Adenocarcinoma///history_of_colon_polyps: NA///history_of_neoadjuvant_treatment: No///icd_10: C19///icd_o_3_histology: 8140/3///icd_o_3_site: C19.9///informed_consent_verified: YES///kras_gene_analysis_performed: YES///kras_mutation_codon: NA///kras_mutation_found: NO///loss_expression_of_mismatch_repair_proteins_by_ihc: NA///loss_expression_of_mismatch_repair_proteins_by_ihc_result: NA///lymph_node_examined_count: 16///lymphatic_invasion: NO///microsatellite_instability: NO///non_nodal_tumor_deposits: NA///number_of_abnormal_loci: 0///number_of_first_degree_relatives_with_cancer_diagnosis: NA///number_of_loci_tested: 5///number_of_lymphnodes_positive_by_he: 0///number_of_lymphnodes_positive_by_ihc: NA///pathologic_M: M0///pathologic_N: N0///pathologic_T: T3///pathologic_stage: Stage IIA///patient_id: A1DC///perineural_invasion_present: NA///preoperative_pretreatment_cea_level: NA///primary_lymph_node_presentation_assessment: YES///primary_pattern: NA///prior_dx: No///psa_value: NA///race: WHITE///residual_tumor: NA///secondary_pattern: NA///synchronous_colon_cancer_present: NO///system_version: NA///tertiary_pattern: NA///tissue_source_site: DY///tumor_tissue_site: Rectum///venous_invasion: NO///weight: 68///year_of_initial_pathologic_diagnosis: 2000///additional_pharmaceutical_therapy: NA///additional_radiation_therapy: YES///additional_surgery_locoregional_procedure: YES///additional_surgery_metastatic_procedure: NA///bcr_followup_uuid: FD4A2C05-AD6E-44F9-8FCC-7F7A2021A946///date_of_form_completion: 2011-12-2///days_to_additional_surgery_locoregional_procedure: 817///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: 1257///days_to_last_followup: 1257///days_to_new_tumor_event_after_initial_treatment: 630///followup_case_report_form_submission_reason: Scheduled Follow-up Submission///new_tumor_event_after_initial_treatment: YES///person_neoplasm_cancer_status: NA///radiation_therapy: NA///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: NA///vital_status: Dead///Extract.Name: TCGA-DY-A1DC-01A-31R-A155-07///unique_patient_id: TCGA-DY-A1DC"
"TCGA-DY-A1DD-01A-21R-A155-07"	"TCGA-DY-A1DD"	"TCGA-DY-A1DD-01A-21R-A155-07"	"tumor"	"re"	NA	NA	"late"	"3"	"1"	"0"	NA	77	NA	"norecurrence"	1741	"deceased"	NA	"MSS"	"rectosigmoid"	"l"	"f"	"wt"	NA	NA	NA	NA	16	1	"3"	"caucasian"	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"age_at_initial_pathologic_diagnosis: 77///anatomic_neoplasm_subdivision: Rectosigmoid Junction///b_symptoms: NA///bcr_patient_uuid: 813bb368-9389-4528-9b18-387374bc912f///braf_gene_analysis_performed: YES///braf_gene_analysis_result: Normal///circumferential_resection_margin: NA///clinical_M: NA///clinical_N: NA///clinical_T: NA///clinical_stage: NA///colon_polyps_present: NA///days_to_birth: -28159///days_to_initial_pathologic_diagnosis: 0///days_to_last_known_alive: 1741///days_to_psa: NA///ethnicity: NOT HISPANIC OR LATINO///extranodal_involvement: NA///gender: FEMALE///gleason_score: NA///height: 156///histological_type: Rectal Adenocarcinoma///history_of_colon_polyps: NA///history_of_neoadjuvant_treatment: No///icd_10: C19///icd_o_3_histology: 8140/3///icd_o_3_site: C19.9///informed_consent_verified: YES///kras_gene_analysis_performed: YES///kras_mutation_codon: NA///kras_mutation_found: NO///loss_expression_of_mismatch_repair_proteins_by_ihc: NA///loss_expression_of_mismatch_repair_proteins_by_ihc_result: NA///lymph_node_examined_count: 16///lymphatic_invasion: NA///microsatellite_instability: NO///non_nodal_tumor_deposits: NA///number_of_abnormal_loci: 0///number_of_first_degree_relatives_with_cancer_diagnosis: 0///number_of_loci_tested: 5///number_of_lymphnodes_positive_by_he: 1///number_of_lymphnodes_positive_by_ihc: NA///pathologic_M: M0///pathologic_N: N1///pathologic_T: T3///pathologic_stage: Stage IIIB///patient_id: A1DD///perineural_invasion_present: NA///preoperative_pretreatment_cea_level: NA///primary_lymph_node_presentation_assessment: YES///primary_pattern: NA///prior_dx: No///psa_value: NA///race: WHITE///residual_tumor: NA///secondary_pattern: NA///synchronous_colon_cancer_present: NO///system_version: NA///tertiary_pattern: NA///tissue_source_site: DY///tumor_tissue_site: Rectum///venous_invasion: NA///weight: 42///year_of_initial_pathologic_diagnosis: 1999///additional_pharmaceutical_therapy: NA///additional_radiation_therapy: NA///additional_surgery_locoregional_procedure: NA///additional_surgery_metastatic_procedure: NA///bcr_followup_uuid: 58653763-6128-40AA-BCF5-01E1D8EF1CC1///date_of_form_completion: 2011-12-2///days_to_additional_surgery_locoregional_procedure: NA///days_to_additional_surgery_metastatic_procedure: NA///days_to_death: 1741///days_to_last_followup: 1741///days_to_new_tumor_event_after_initial_treatment: NA///followup_case_report_form_submission_reason: Scheduled Follow-up Submission///new_tumor_event_after_initial_treatment: NO///person_neoplasm_cancer_status: NA///radiation_therapy: NA///residual_disease_post_new_tumor_event_margin_status: NA///site_of_additional_surgery_new_tumor_event_mets: NA///targeted_molecular_therapy: NA///vital_status: Dead///Extract.Name: TCGA-DY-A1DD-01A-21R-A155-07///unique_patient_id: TCGA-DY-A1DD"
